Antibiotic resistance can develop to new antibiotics even before they reach the market, undermining their future ...

Recce’s new compound is a broad-spectrum antibiotic initially to be used intravenously against Escherichia coli and Staphylococcus aureus bacteria in the blood, including superbug forms.

Tygacil (tigecycline)is a new, expanded broad-spectrum IV antibiotic that can be used for the treatment of a wide range of infections. Tygacil (tigecycline)is a new, expanded broad-spectrum IV ...